TOPIC
WHAT HAPPENS
FINDINGS
CLUE
Inhaled droplets → alveolar macrophages → Th1 response
Ghon focus (subpleural, lower upper/upper lower lobe) + hilar node = Ghon complex; calcifies → Ranke complex
Mostly asymptomatic; children may have hilar adenopathy
Contained in granulomas
+ PPD or IGRA, normal chest X-ray, no symptoms
Treat to prevent reactivation (rifampin 4 mo, isoniazid 6–9 mo, or INH + rifapentine)
Secondary (reactivation) TB
Waning immunity (HIV, age, steroids, TNF-α inhibitors, diabetes, silicosis)
Apical fibrocaseous cavities, fever, night sweats, weight loss, hemoptysis
Most transmissible form
Progressive primary / miliary
Poor immunity (infants, AIDS) → hematogenous spread
Millet-seed nodules in lungs, liver, spleen, marrow, meninges
Can follow primary or reactivation
Basilar meninges
Subacute headache, CN palsies, hydrocephalus; CSF: lymphocytes, very high protein, low glucose
Add dexamethasone
Vertebral osteomyelitis (thoracic)
Back pain, gibbus deformity, psoas abscess
—
Hematogenous seeding
Scrofula (cervical lymphadenitis), adrenal insufficiency, sterile pyuria, pericarditis, peritonitis, ileocecal disease, erythema nodosum
"Sterile pyuria" → TB of kidney
Type IV hypersensitivity to tuberculin, read at 48–72 h
Induration ≥ 5 mm (HIV, contacts, steroids), ≥ 10 mm (high risk, healthcare), ≥ 15 mm (no risk)
False ⁺: BCG, NTM · false −: anergy (HIV, sarcoid, steroids, malnutrition)
T cells release IFN-γ to TB-specific antigens (ESAT-6, CFP-10)
One blood draw
Not affected by BCG
Sputum × 3: AFB smear, culture (gold standard, weeks), NAAT
Chest X-ray, CT
Airborne isolation (N95, negative pressure)
RIPE: rifampin, isoniazid, pyrazinamide, ethambutol × 2 mo → RI × 4 mo
Directly observed therapy
Pyridoxine with isoniazid (see 11.05)
Live attenuated M bovis
Prevents severe childhood TB (miliary, meningitis)
Not in routine US use · contraindicated in immunocompromised